serw-MX  [xml]  
 


    
 DeCS Categories

D02 Organic Chemicals .
D02.455 Hydrocarbons .
D02.455.426 Hydrocarbons, Cyclic .
D02.455.426.559 Hydrocarbons, Aromatic .
D02.455.426.559.847 Polycyclic Aromatic Hydrocarbons .
D02.455.426.559.847.562 Naphthacenes .
D02.455.426.559.847.562.900 Tetracyclines .
D03 Heterocyclic Compounds .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.679 Pyrazines .
D03.383.679.149 Amiloride .
D03.633 Heterocyclic Compounds, Fused-Ring .
D03.633.100 Heterocyclic Compounds, 2-Ring .
D03.633.100.810 Quinolines .
D03.633.100.810.050 Aminoquinolines .
D03.633.100.810.050.180 Chloroquine .
D03.633.100.810.050.180.350 Hydroxychloroquine .
D03.633.400 Heterocyclic Compounds, 4 or More Rings .
D03.633.400.811 Rifamycins .
D03.633.400.811.700 Rifampin .
D04 Polycyclic Compounds .
D04.210 Fused-Ring Compounds .
D04.210.500 Steroids .
D04.210.500.745 Pregnanes .
D04.210.500.745.745 Pregnenes .
D04.210.500.745.745.654 Pregnenediones .
D04.210.500.745.745.654.237 Corticosterone .
D04.345 Macrocyclic Compounds .
D04.345.295 Lactams, Macrocyclic .
D04.345.295.750 Rifamycins .
D04.345.295.750.700 Rifampin .
D04.615 Polycyclic Aromatic Hydrocarbons .
D04.615.562 Naphthacenes .
D04.615.562.900 Tetracyclines .
D06 Hormones, Hormone Substitutes, and Hormone Antagonists .
D06.472 Hormones .
D06.472.040 Adrenal Cortex Hormones .
D06.472.040.585 Hydroxycorticosteroids .
D06.472.040.585.353 11-Hydroxycorticosteroids .
D06.472.040.585.353.237 Corticosterone .
D06.472.699 Peptide Hormones .
D06.472.699.587 Pancreatic Hormones .
D06.472.699.587.469 Proglucagon .
D06.472.699.587.469.500 Glucagon .
D12 Amino Acids, Peptides, and Proteins .
D12.644 Peptides .
D12.644.276 Intercellular Signaling Peptides and Proteins .
D12.644.276.812 Kinins .
D12.644.548 Peptide Hormones .
D12.644.548.586 Pancreatic Hormones .
D12.644.548.586.469 Proglucagon .
D12.644.548.586.469.500 Glucagon .
D12.776 Proteins .
D12.776.467 Intercellular Signaling Peptides and Proteins .
D12.776.467.812 Kinins .
D23 Biological Factors .
D23.469 Inflammation Mediators .
D23.469.050 Autacoids .
D23.469.050.375 Kinins .
D23.529 Intercellular Signaling Peptides and Proteins .
D23.529.812 Kinins .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.519 Molecular Mechanisms of Pharmacological Action .
D27.505.519.389 Enzyme Inhibitors .
D27.505.519.389.616 Monoamine Oxidase Inhibitors .
D27.505.696 Physiological Effects of Drugs .
D27.505.696.277 Central Nervous System Depressants .
D27.505.696.277.100 Anesthetics .
D27.505.696.277.100.035 Anesthetics, General .
D27.505.696.277.100.035.075 Anesthetics, Intravenous .
D27.505.696.277.100.035.075.035 Anesthetics, Dissociative .
D27.505.696.277.100.200 Anesthetics, Local .
D27.505.696.663 Peripheral Nervous System Agents .
D27.505.696.663.850 Sensory System Agents .
D27.505.696.663.850.025 Anesthetics, Local .
D27.505.954 Therapeutic Uses .
D27.505.954.427 Central Nervous System Agents .
D27.505.954.427.210 Central Nervous System Depressants .
D27.505.954.427.210.100 Anesthetics .
D27.505.954.427.210.100.035 Anesthetics, General .
D27.505.954.427.210.100.035.075 Anesthetics, Intravenous .
D27.505.954.427.210.100.035.075.035 Anesthetics, Dissociative .
D27.505.954.427.210.100.200 Anesthetics, Local .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Tetracyclines .
Antibiotics, Tetracycline .
Tetracycline Antibiotics .
Closely congeneric derivatives of the polycyclic naphthacenecarboxamide. (Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1117) .
1.00
1413649
 
Monoamine Oxidase Inhibitors .
Monoamine Oxidase Inhibitor .
RIMA (Reversible Inhibitor of Monoamine Oxidase A) .
Reversible Inhibitor of Monoamine Oxidase .
Inhibitor, Monoamine Oxidase .
Inhibitors, MAO .
Inhibitors, Monoamine Oxidase .
MAO Inhibitors .
Reversible Inhibitors of Monoamine Oxidase .
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) .
0.56
758610
 
Hydroxychloroquine .
Hydroxychloroquine Sulfate .
Hydroxychloroquine Sulfate (1:1) Salt .
Plaquenil .
Hydroxychlorochin .
Oxychlorochin .
Oxychloroquine .
A chemotherapeutic agent that acts against erythrocytic forms of malarial parasites. Hydroxychloroquine appears to concentrate in food vacuoles of affected protozoa. It inhibits plasmodial heme polymerase. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p970) .
0.46
502366
 
Anesthetics, Dissociative .
Dissociative Anesthetics .
Intravenous anesthetics that induce a state of sedation, immobility, amnesia, and marked analgesia. Subjects may experience a strong feeling of dissociation from the environment. The condition produced is similar to NEUROLEPTANALGESIA, but is brought about by the administration of a single drug. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) .
0.45
242210
 
Corticosterone .
An adrenocortical steroid that has modest but significant activities as a mineralocorticoid and a glucocorticoid. (From Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p1437) .
0.40
6423476
 
Glucagon .
Glucagon (1-29) .
Glukagon .
HG-Factor .
Hyperglycemic-Glycogenolytic Factor .
Proglucagon (33-61) .
HG Factor .
Hyperglycemic Glycogenolytic Factor .
A 29-amino acid pancreatic peptide derived from proglucagon which is also the precursor of intestinal GLUCAGON-LIKE PEPTIDES. Glucagon is secreted by PANCREATIC ALPHA CELLS and plays an important role in regulation of BLOOD GLUCOSE concentration, ketone metabolism, and several other biochemical and physiological processes. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1511) .
0.38
 
Rifampin .
Benemycin .
Rifadin .
Rimactan .
Rimactane .
Tubocin .
Rifampicin .
A semisynthetic antibiotic produced from Streptomyces mediterranei. It has a broad antibacterial spectrum, including activity against several forms of Mycobacterium. In susceptible organisms it inhibits DNA-dependent RNA polymerase activity by forming a stable complex with the enzyme. It thus suppresses the initiation of RNA synthesis. Rifampin is bactericidal, and acts on both intracellular and extracellular organisms. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p1160) .
0.38
45016316
 
Amiloride .
Amidal .
Amiduret Trom .
Amiloberag .
Amiloride Hydrochloride .
Amiloride Hydrochloride, Anhydrous .
Kaluril .
Midamor .
Midoride .
Modamide .
Anhydrous Amiloride Hydrochloride .
Hydrochloride, Amiloride .
Hydrochloride, Anhydrous Amiloride .
Trom, Amiduret .
A pyrazine compound inhibiting SODIUM reabsorption through SODIUM CHANNELS in renal EPITHELIAL CELLS. This inhibition creates a negative potential in the luminal membranes of principal cells, located in the distal convoluted tubule and collecting duct. Negative potential reduces secretion of potassium and hydrogen ions. Amiloride is used in conjunction with DIURETICS to spare POTASSIUM loss. (From Gilman et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 9th ed, p705) .
0.37
287289
 
Anesthetics, Local .
Anesthetics, Topical .
Anesthetics, Conduction Blocking .
Conduction Blocking Anesthetics .
Local Anesthetics .
Anesthetics, Conduction-Blocking .
Conduction-Blocking Anesthetics .
Drugs that block nerve conduction when applied locally to nerve tissue in appropriate concentrations. They act on any part of the nervous system and on every type of nerve fiber. In contact with a nerve trunk, these anesthetics can cause both sensory and motor paralysis in the innervated area. Their action is completely reversible. (From Gilman AG, et. al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed) Nearly all local anesthetics act by reducing the tendency of voltage-dependent sodium channels to activate. .
0.36
71528925
 
Kinins .
A generic term used to describe a group of polypeptides with related chemical structures and pharmacological properties that are widely distributed in nature. These peptides are AUTACOIDS that act locally to produce pain, vasodilatation, increased vascular permeability, and the synthesis of prostaglandins. Thus, they comprise a subset of the large number of mediators that contribute to the inflammatory response. (From Goodman and Gilman's The Pharmacologic Basis of Therapeutics, 8th ed, p588) .
0.34
383848